ARTICLE | Clinical News
Large unilamellar vesicles: Began Phase IIa trial
January 16, 2001 8:00 AM UTC
Esperion Therapeutics Inc. (ESPR), Ann Arbor, Mich. Product: Large unilamellar vesicles (LUVs) Business: Cardiovascular Therapeutic category: Cholesterol transport Target: Cholesterol Description: Lip...